Skandinaviska Enskilda Banken (SEB)
CNST

Skandinaviska Enskilda Banken (SEB)’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,404
Closed -$1.23M – 1129
2021
Q2 		$1.23M Buy
+36,404
New +$928K 0.01% 777

Skandinaviska Enskilda Banken (SEB)'s CNST Position: Q3 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 36,404 shares — an estimated $1.23M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.23M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 36,404 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.23M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Constellation Pharmaceuticals, Inc. position peaked at $1.23M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2021, filed 10 Nov 2021.